Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo.

@article{Camacho2002OralAT,
  title={Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo.},
  author={Francisco Miguel Camacho and Jos{\'e} Mazuecos},
  journal={Journal of drugs in dermatology : JDD},
  year={2002},
  volume={1 2},
  pages={127-31}
}
BACKGROUND Vitiligo is a hypopigmented skin condition that usually requires a combination of treatment options. AIM To demonstrate the effectiveness of topical and oral L-phenylalanine in combination with light plus 0.025% clobetasol propionate at night. PATIENTS AND METHODS We have performed an open trial on a group of 70 patients with evolutive vitiligo. Participants were treated with oral (100 mg/Kg/day) and topical (gel at 10%) L-phenylalanine, exposed to sunlight (spring-summer) or UVA… CONTINUE READING